Navigation Links
Isis Adds New Drug to Its Development Pipeline: ISIS 388626 Targeting SGLT2 for the Treatment of Type 2 Diabetes
Date:10/18/2007

ompany has successfully commercialized the world's first antisense drug and has 18 drugs in development. Isis' drug development programs are focused on treating cardiovascular and metabolic diseases. Isis' partners are developing drugs for a wide variety of diseases. Ibis Biosciences, Inc., Isis' wholly owned subsidiary, is developing and commercializing the Ibis T5000(TM) Biosensor System, a revolutionary system to identify infectious organisms. As an innovator in RNA-based drug discovery and development, Isis is the owner or exclusive licensee of over 1,500 issued patents worldwide, and Isis is a joint owner of Regulus Therapeutics, LLC, a company focused on the discovery, development and commercialization of microRNA therapeutics. Additional information about Isis is available at http://www.isispharm.com.

This press release includes forward-looking statements regarding Isis' business, its drug discovery and development pipeline, and the therapeutic and commercial potential for ISIS 388626 for the treatment of diabetes. Any statement describing Isis' goals, expectations, financial or other projections, intentions or beliefs is a forward-looking statement and should be considered an at-risk statement, including those statements that are described as Isis' goals. Such statements are subject to certain risks and uncertainties, particularly those inherent in the process of discovering, developing and commercializing drugs that are safe and effective for use as human therapeutics, and in the endeavor of building a business around such products. Isis' forward-looking statements also involve assumptions that, if they never materialize or prove correct, could cause its results to differ materially from those expressed or implied by such forward-looking statements. Although Isis' forward-looking statements reflect the good faith judgment of its management, these statements are based only on facts and factors curren
'/>"/>

SOURCE Isis Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Developmental, neurologic problems common in extremely preterm infants
2. Cancer drugs in development nearly doubled since 1995
3. Development of AIDS vaccine -- Chiron Corp in talks with four Indian cos
4. Role of zinc in development
5. Particulate matter affects lung development
6. Fossil teeth and human development
7. High development costs hinder entry of cancer super drugs into the market
8. Fireflies help speed development of new drugs
9. AEternas acquisition of Zentaris being followed up with its new product pipeline and clinical development strategy
10. New fertility drug development techniques by Organon
11. Biosensor chip to help drug development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... ... September 01, 2015 , ... Stress comes in ... from everyday life changes can lead to very serious, life-altering events. Fortunately nature ... with stress. Herbal supplement manufacturer MediHerb has coupled therapeutic doses of ...
(Date:9/1/2015)... ... September 01, 2015 , ... Philanthropic giving in the U.S. has ... and needs. Money for Good 2015, released today by Camber Collective, goes to the ... potential to mobilize up to $22B in new philanthropic giving and shift $25B that’s ...
(Date:9/1/2015)... , ... September 01, 2015 ... ... better therapeutic options to efficiently cure and prevent different malignancies. Some options ... have different pathophysiological properties due to which distinctive approach is necessary for ...
(Date:9/1/2015)... Jose, CA (PRWEB) , ... September 01, 2015 ... ... cross-device computing and collaboration, announces Splashtop Business for Remote Support , a ... remote support solution. Unhappy with the escalating renewal prices and inadequate customer ...
(Date:9/1/2015)... ... September 01, 2015 , ... Plaza OBGYN ... MonaLisa Touch® , an innovative vaginal health laser procedure that prevents and ... hormone-free treatment for atrophic vaginitis, a condition that causes vaginal dryness, pelvic discomfort, ...
Breaking Medicine News(10 mins):Health News:MediHerb Launches New Herbal Supplement to Help with the Challenges of Everyday Life 2Health News:MediHerb Launches New Herbal Supplement to Help with the Challenges of Everyday Life 3Health News:Camber Collective Releases Money for Good 2015 - Revealing Root Causes to Why Charitable Giving Has Been Stuck at 2% GDP Since the 70s 2Health News:Camber Collective Releases Money for Good 2015 - Revealing Root Causes to Why Charitable Giving Has Been Stuck at 2% GDP Since the 70s 3Health News:CD Antigen Cancer Market and Pipeline Landscape Examined in Comprehensive Kuick Research Report Published at MarketPublishers.com 2Health News:CD Antigen Cancer Market and Pipeline Landscape Examined in Comprehensive Kuick Research Report Published at MarketPublishers.com 3Health News:Splashtop Launches Splashtop Business for Remote Support, the Simple, Reliable, and Cost-Effective Solution for MSPs and IT Professionals 2Health News:Splashtop Launches Splashtop Business for Remote Support, the Simple, Reliable, and Cost-Effective Solution for MSPs and IT Professionals 3Health News:Splashtop Launches Splashtop Business for Remote Support, the Simple, Reliable, and Cost-Effective Solution for MSPs and IT Professionals 4Health News:Houston's Plaza OB/GYN Now Offering the MonaLisa Touch® 2Health News:Houston's Plaza OB/GYN Now Offering the MonaLisa Touch® 3
... A complex autoimmune disease, rheumatoid arthritis (RA) is characterized ... begins with hyperplasia//, or excessive increase in size and ... bone destruction, this abnormal tissue growth is resistant to ... of healthy new cells. ,Decoy receptor 3 ...
... vaccine, administered in childhood to guard against pneumonia, meningitis//, and ... to pneumonia. ,The Centers for Disease Control has ... get four doses of the vaccine when they turn two. ... missed out on the vaccine, should take the shot without ...
... you if you have cancer or are at high risk of ... appear? ,Research happening today at the University of Michigan ... New genetic markers and proteins are being discovered that can identify ... ,But what does this progress mean to the average ...
... Awareness Week (NAW) kicks off this year from ... the American Association// of Neurological Surgeons (AANS) in ... meet in the nation’s capital to further their ... pain, spine and peripheral nerves, pediatrics, stereotactic, trauma, ...
... new standards to assess nutrition in children could lead to ... eligible// for emergency feeding programs, warn researchers in this week’s ... the number of nutritional emergencies has risen over the last ... the 1980s to more than 30 per year since 2000. ...
... treatment developed by a pediatric orthopedic surgeon has shown ... The treatment for rigid flatfoot//, which once required extensive ... ,Congenital vertical talus (CVT), or "rocker-bottom flat ... Left untreated, the patient would walk on the inside ...
Cached Medicine News:Health News:A Newly Identified Immunosuppressive Protein in Rheumatoid Arthritis 2Health News:Can Science Stop Cancer Before It Starts? 2Health News:National Neurosurgery Awareness Week Kicks Off During Annual Meeting of the AANS 2Health News:New Standards Could Cut Number of Malnourished Children on Feeding Programs 2Health News:Foot Deformity Could Be Corrected With Minimal Surgery 2
(Date:9/1/2015)... Sept. 1, 2015  AccuTec Blades, Inc. today announced ... Blades division.  EPC announced in May 2015 its intent ... Verona, Virginia and Obregon, Mexico ... sale process. Rick Gagliano , ... Blades said, "Our new name, AccuTec Blades, reflects the ...
(Date:9/1/2015)... --NOWDiagnostics Inc., based in Springdale, Ark. , ... Canada , a move that brings the company ... have greater access to information concerning their health. ... blood-based rapid tests that allow health care providers to ... ailments and diseases. ZBx Corporation, a Toronto ...
(Date:9/1/2015)... DALLAS , Sept. 1, 2015 UT ... and distinguished faculty members joined U.S. Representatives ... in a roundtable discussion on the 21 st ... biomedical research currently being considered by the ... faculty – including National Academy of Sciences members, department ...
Breaking Medicine Technology:AccuTec Blades, Inc. Announces Acquisition of Industrial Blades Division from Edgewell Personal Care Company 2NOWDiagnostics Inc. Acquires Canada's ZBx Corporation 2NOWDiagnostics Inc. Acquires Canada's ZBx Corporation 3U.S. Rep. Michael C. Burgess, M.D., hosts roundtable at UT Southwestern to discuss pivotal 21st Century Cures Act and future of biomedical science 2U.S. Rep. Michael C. Burgess, M.D., hosts roundtable at UT Southwestern to discuss pivotal 21st Century Cures Act and future of biomedical science 3U.S. Rep. Michael C. Burgess, M.D., hosts roundtable at UT Southwestern to discuss pivotal 21st Century Cures Act and future of biomedical science 4U.S. Rep. Michael C. Burgess, M.D., hosts roundtable at UT Southwestern to discuss pivotal 21st Century Cures Act and future of biomedical science 5
... Conn., May 15, 2012 /PRNewswire-iReach/ -- Global ... important Cambridge Healthtech Institute conferences: IMVACS – ... August 13 – 15, Cambridge, MA - The ... under one heading: the Seventh Annual Novel Vaccines, Design ...
... Labs, Inc. (OTCQB/OTCBB: GOVX), a biotechnology company that creates, ... results for the three months ended March 31, 2012 ... delighted with recent developments that have strengthened and advanced ... David Dodd. "Our Phase 1/2 therapeutic vaccine trial continues ...
Cached Medicine Technology:Attendees Save up to $350 on CHI Conferences This Summer by Registering Through Global Information 2GeoVax Labs Reports 2012 First Quarter Financial Results 2GeoVax Labs Reports 2012 First Quarter Financial Results 3GeoVax Labs Reports 2012 First Quarter Financial Results 4GeoVax Labs Reports 2012 First Quarter Financial Results 5GeoVax Labs Reports 2012 First Quarter Financial Results 6
Straight shafts with 0.12 mm teeth and tying platform. Serrated handle with polished finish....
Angled 45 degree shafts with 1 x 2 teeth and 5 mm tying platform. Serrated handle with dull finish....
Heavy curved shafts with 2 x 2 teeth and crisscross serrated 6 mm tying platform. Serrated handle with polished finish....
Straight shafts with 1 x 2 teeth and 6 mm tying platform. Wide serrated handle with polished finish....
Medicine Products: